Insider · CIK 0001686295

Yurasov Sergey

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001686295

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-21	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+250K sh	—	—	250,000
2025-01-30	BDTXBlack Diamond Therapeutics, Inc.A Award	CHIEF MEDICAL OFFICER	AAward	+75K sh	—	—	75,000
2025-01-30	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+200K sh	—	—	200,000
2024-02-14	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+225K sh	—	—	225,000
2023-02-13	BDTXBlack Diamond Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CHIEF MEDICAL OFFICER	AAward	+250K sh	—	—	250,000
2021-02-10	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+399K sh	—	—	398,935
2021-02-10	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+399K sh	—	—	398,935
2019-04-02	IMMUNE DESIGN CORP.D Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−6,136 sh	$5.85	−$35.9K	0
2019-04-02	IMMUNE DESIGN CORP.Restricted Stock UnitsD Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−72.6K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−110K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−113K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−110K sh	—	—	0
2019-01-07	IMMUNE DESIGN CORP.S Sale	Sr. VP, Clinic. Devel. & CMO	SSale	−3,522 sh	$1.57	−$5,535.527	78,756
2019-01-03	IMMUNE DESIGN CORP.A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+25K sh	—	—	82,278
2019-01-03	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+110K sh	—	—	110,000
2018-11-07	IMMUNE DESIGN CORP.A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+30K sh	—	—	57,278
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−52.8K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+35.2K sh	—	—	35,179
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−87.2K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+58.2K sh	—	—	58,155
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−625 sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+417 sh	—	—	417
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Sr. VP, Clinic. Devel. & CMO	DDisposition to Issuer	−29.4K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+19.6K sh	—	—	19,584
2018-01-04	IMMUNE DESIGN CORP.A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+22K sh	—	—	28,000
2018-01-04	IMMUNE DESIGN CORP.S Sale	Sr. VP, Clinic. Devel. & CMO	SSale	−675 sh	$4.17	−$2,816.438	27,325
2018-01-04	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+110K sh	—	—	110,000
2017-01-04	IMMUNE DESIGN CORP.A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+6,000 sh	—	—	6,000
2017-01-04	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+30K sh	—	—	30,000
2016-10-01	IMMUNE DESIGN CORP.Employee Stock Option (right to buy)A Award	Sr. VP, Clinic. Devel. & CMO	AAward	+140K sh	—	—	140,000

Recent filings

Accepted (ET)
Jan 234
Yurasov Sergey0001686295-26-000002
SEC(opens sec.gov)
Jan 314
Yurasov Sergey0001415889-25-002493
SEC(opens sec.gov)
Feb 154
Yurasov Sergey0001415889-24-003967
SEC(opens sec.gov)
Feb 154
Yurasov Sergey0001104659-23-022391
SEC(opens sec.gov)
Feb 124
Yurasov Sergey0001209191-21-010332
SEC(opens sec.gov)
Apr 44
Yurasov Sergey0001209191-19-023688
SEC(opens sec.gov)
Jan 74
Yurasov Sergey0001209191-19-002669
SEC(opens sec.gov)
Nov 94
Yurasov Sergey0001209191-18-057941
SEC(opens sec.gov)
Jul 194
Yurasov Sergey0001209191-18-043393
SEC(opens sec.gov)

Companies

Address

C/O BLACK DIAMOND THERAPEUTICS, INC. 245 FIRST STREET, 18TH FLOOR

CAMBRIDGE, MA, 02142